Physician Office Labs At Cholestech’s Fingertips: CRP, Waived Tests In Reach
This article was originally published in The Gray Sheet
Executive Summary
Cholestech will conduct clinical studies to support Medicare reimbursement for Endo-Pat 2000, a device that measures vascular endothelial dysfunction, an early-stage marker of atherosclerosis